← Leaderboards
Samuel M Moskowitz
University Of Washington
$3,526,859
Attributed
$3,526,859
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $683.4K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,526,859 · 6
By mechanism
R01$2,466,424 · 1
K08$628,290 · 1
R21$412,448 · 1
M01$19,697 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Robert K Ernst$6,785,080
- Samuel I. Miller$34,128,042
- Richard Peters Darveau$12,034,617
- Margaret Rosenfeld$6,120,159
- Beverly A Dale-Crunk$4,537,579
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisPseudomonas AeruginosaHuman SubjectLung DisorderPatient Oriented ResearchCd14 MoleculeGenetic SusceptibilityMolecular PathologyLipopolysaccharidesAntibioticsBactericidal ImmunityBacterial GeneticsBaseBinding (Molecular Function)AminoarabinoseDependenceCollectionBacteria Infection MechanismChemical Structure FunctionColistinAdultChronicClinical MicrobiologyCell Wall Alteration
Grant awards (15)
Polymyxin-resistant Pseudomonas in CF Lung Infection$683,379
R01 · FY2010 · AI · contact PI
Polymyxin-resistant Pseudomonas in CF Lung Infection$580,593
R01 · FY2009 · AI · contact PI
Polymyxin-resistant Pseudomonas in CF Lung Infection$571,018
R01 · FY2008 · AI · contact PI
Polymyxin-resistant Pseudomonas in CF Lung Infection$631,434
R01 · FY2007 · AI · contact PI
Influence of ENaC Regulators on CF Lung Severity$185,048
R21 · FY2006 · HL · contact PI
STANDARD VERSUS BIOFILM SUSCEPTIBILITY TESTING IN CYSTIC FIBROSIS (CF)$826
M01 · FY2006 · RR · contact PI
Influence of ENaC Regulators on CF Lung Severity$227,400
R21 · FY2005 · HL
Host-Pathogen Interactions in Cystic Fibrosis$125,658
K08 · FY2005 · HL
GENETICS OF CYSTIC FIBROSIS LUNG SPARING$4,991
M01 · FY2005 · RR
Host-Pathogen Interactions in Cystic Fibrosis$125,658
K08 · FY2004 · HL
Genetics of Cystic Fibrosis Lung Sparing$13,012
M01 · FY2004 · RR
Genetics of cystic fibrosis lung disease$868
M01 · FY2004 · RR
Host-Pathogen Interactions in Cystic Fibrosis$125,658
K08 · FY2003 · HL
Host-Pathogen Interactions in Cystic Fibrosis$125,658
K08 · FY2002 · HL
Host-Pathogen Interactions in Cystic Fibrosis$125,658
K08 · FY2001 · HL